- Home
- VIR vs DGII Comparison
VIR vs DGII Comparison
Compare VIR & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- DGII
- Stock Information
- Founded
- VIR 2016
- DGII 1985
- Country
- VIR United States
- DGII United States
- Employees
- VIR N/A
- DGII N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- DGII Computer peripheral equipment
- Sector
- VIR Health Care
- DGII Technology
- Exchange
- VIR Nasdaq
- DGII Nasdaq
- Market Cap
- VIR 844.9M
- DGII 976.7M
- IPO Year
- VIR 2019
- DGII N/A
- Fundamental
- Price
- VIR $5.41
- DGII $32.02
- Analyst Decision
- VIR Strong Buy
- DGII Hold
- Analyst Count
- VIR 7
- DGII 4
- Target Price
- VIR $33.57
- DGII $33.50
- AVG Volume (30 Days)
- VIR 1.0M
- DGII 186.9K
- Earning Date
- VIR 05-07-2025
- DGII 05-07-2025
- Dividend Yield
- VIR N/A
- DGII N/A
- EPS Growth
- VIR N/A
- DGII 196.64
- EPS
- VIR N/A
- DGII 1.13
- Revenue
- VIR $20,861,000.00
- DGII $418,624,000.00
- Revenue This Year
- VIR N/A
- DGII $1.63
- Revenue Next Year
- VIR $10.65
- DGII $4.86
- P/E Ratio
- VIR N/A
- DGII $28.40
- Revenue Growth
- VIR N/A
- DGII N/A
- 52 Week Low
- VIR $4.95
- DGII $20.17
- 52 Week High
- VIR $14.45
- DGII $37.07
- Technical
- Relative Strength Index (RSI)
- VIR 35.98
- DGII 72.49
- Support Level
- VIR $5.83
- DGII $27.55
- Resistance Level
- VIR $6.29
- DGII $28.95
- Average True Range (ATR)
- VIR 0.31
- DGII 0.95
- MACD
- VIR 0.02
- DGII 0.49
- Stochastic Oscillator
- VIR 28.80
- DGII 83.48
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About DGII Digi International Inc.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.